Oxygen Therapy Industry Summary:
- The global oxygen therapy market size reached USD 20.2 Billion in 2024.
- The market is expected to reach USD 34.4 Billion by 2033, exhibiting a growth rate (CAGR) of 6.05% during 2025-2033.
- Oxygen source equipment accounts for the majority of the market share in the product segment due to the prevalence of chronic respiratory diseases, and innovations in oxygen delivery systems.
- Chronic obstructive pulmonary disease holds the largest share of the application segment due to the significant incidence rate worldwide.
- Home healthcare accounts for the majority of the end use segment due to cost-efficiency and patient preference for treatment in familiar settings.
- North America holds the leading position in the region segment due to advanced medical technology and increased awareness of respiratory care solutions.
- The market is witnessing a shift towards portable and technologically advanced oxygen delivery systems, which are enhancing patient accessibility and compliance.
- Government initiatives and funding are supporting awareness and infrastructure development, driving market growth in both emerging and established regions.
The latest report by IMARC Group, titled “Oxygen Therapy Market Report by Product (Oxygen Source Equipment, Oxygen Delivery Devices), Application (Chronic Obstructive Pulmonary Disease, Asthma, Obstructive Sleep Apnea, Respiratory Distress Syndrome, Cystic Fibrosis, Pneumonia, and Others), End Use (Home Healthcare, Hospitals), and Region 2025-2033,” offers a comprehensive analysis of the oxygen therapy market report. The report also includes competitor and regional analysis, along with a breakdown of segments within the industry.
Request Free Sample Report: https://www.imarcgroup.com/oxygen-therapy-market/requestsample
Industry Trends and Drivers:
- Rising Prevalence of Chronic Respiratory Diseases:
The increasing prevalence of chronic respiratory illnesses, such as COPD and asthma, is driving the market. The increasing older population and rapid urbanization are contributing to the rise in these conditions. Patients need oxygen therapy to manage their symptoms, which is pushing demand for treatment solutions that prioritize comfort and mobility.
Non-invasive delivery methods and portable oxygen concentrators are gaining popularity due to their convenience and improved patient compliance. The ongoing global health challenges are emphasizing the importance of oxygen therapy in emergency care, propelling the market forward. These factors are driving the oxygen therapy market share and ensuring continuous reliance on oxygen-based treatments.
- Technological Advancements in Oxygen Delivery Systems:
Continual technological advancements in oxygen delivery systems are transforming patient care and influencing the oxygen therapy market size. Modern devices focus on portability, efficiency, and ease of use, appealing to both at-home patients and clinical settings. Innovations like pulse-dose technology are optimizing oxygen usage while enhancing the patient's experience.
Systems integrated with smart technology for remote monitoring are helping patients manage their health more effectively. These advancements are encouraging more widespread use and making oxygen therapy more accessible. The market is expanding as these improved products are meeting the diverse needs of healthcare providers and patients, supporting growth across different regions.
- Increasing Government Initiatives and Funding:
Governments are implementing initiatives to strengthen healthcare infrastructure, significantly impacting the market. Public health campaigns and subsidies are raising awareness about oxygen therapy’s importance in treating chronic and acute respiratory conditions. Authorities are promoting better medical facilities, particularly in developing regions, which is helping establish more efficient oxygen supply chains and access to equipment.
These initiatives are aligning with global health objectives and preparing systems for respiratory emergencies. Policymakers are encouraging collaborations between healthcare providers and technology innovators to ensure reliable supplies and new developments. These efforts are shaping oxygen therapy market trends and driving growth through combined public and private sector support.
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/oxygen-therapy-market
Oxygen Therapy Market Report Segmentation:
Breakup By Product:
- Oxygen Source Equipment
- Oxygen Cylinders
- Oxygen Concentrators
- Liquid Oxygen Devices
- PAP Devices
- Oxygen Delivery Devices
- Oxygen Masks
- Nasal Cannula
- Venturi Masks
- Non-rebreather Masks
- Bag Valve Masks
- CPAP Masks
- Others
Oxygen source equipment holds the leading market position due to technological advancements and the rising availability of portable concentrators that enhance patient mobility and comfort.
Breakup By Application:
- Chronic Obstructive Pulmonary Disease
- Asthma
- Obstructive Sleep Apnea
- Respiratory Distress Syndrome
- Cystic Fibrosis
- Pneumonia
- Others
Chronic obstructive pulmonary disease holds the leading market position due to its high global prevalence and the growing focus on improved patient management strategies.
Breakup By End Use:
- Home Healthcare
- Hospitals
Home healthcare holds the leading market position as more individuals seek medical treatments outside hospitals, driven by the desire for personalized and convenient care.
Breakup By Region:
- North America (USA, Canada)
- Europe (Germany, France, UK, Italy, Spain, Russia, others)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, others)
- Middle East/Africa
- Latin America (Brazil, Mexico, others)
North America holds the leading market position due to expanding healthcare infrastructure, supportive government policies, and a high rate of chronic respiratory conditions.
Top Oxygen Therapy Market Leaders:
The oxygen therapy market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:
- Allied Healthcare Products Inc.
- Becton Dickinson and Company
- DeVilbiss Healthcare LLC (Drive Medical Inc.)
- Fisher & Paykel Healthcare Limited
- General Electric Company
- Getinge AB
- Hersill SL
- Invacare Corporation
- Koninklijke Philips N.V
- Smiths Group plc
- Tecno-Gaz S.p.A.
- Teleflex Incorporated
About US:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.
IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
Comments
0 comment